Bea Bakshi: Bringing C the Signs, AI-led cancer prediction platform to the US
Bea Bakshi, CEO & Co-Founder of C the Signs, shared on LinkedIn:
Honoured to share The Wall Street Journal announcement that Khosla Ventures is investing $8 million in C the Signs as we bring our AI-led cancer prediction platform to the US.
C the Signs has already helped to identify 30,000 patients with cancer in the NHS, and now, we’re taking this technology further – ensuring more patients have access to earlier detection when it matters most.
Cancer remains one of the leading causes of death worldwide, and early detection is the single most powerful tool we have to save lives. Khosla Ventures is renowned for backing technologies that fundamentally change industries and improve lives – from Open AI to AI-driven healthcare. Their belief in this mission reinforces what we’ve always known: the future of cancer detection is predictive, not reactive.
A huge thank you to my brilliant co-founder, Miles Payling, our team, partners, and the dedicated healthcare professionals driving this change. Looking forward to working with Hal Paz, Alexander A. Morgan, Vinod Khosla, and the whole team at Khosla Ventures to take this impact even further.
Thank you to The Wall Street Journal and Brian Gormley for covering this milestone.
CancerX reshared the post on LinkedIn, adding:
Celebrating Innovation & Impact in Cancer Detection!
A huge congratulations to C the Signs on their incredible milestone!
The announcement of $8M in funding from Khosla Ventures is a testament to their groundbreaking work in AI-driven cancer prediction and early detection.
As an inaugural CancerX Accelerator alum, C the Signs exemplifies the power of innovation, collaboration, and dedication to AI-driven healthcare solutions.
To Dr Bea Bakshi, and the entire C the Signs team—we celebrate your impact and look forward to seeing your continued success!
The momentum for digital health innovation in oncology is stronger than ever.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023